(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
DNA testing company 23andMe’s CEO Anne Wojcicki is looking to take the company private, according to a Wednesday securities filing.
Wojcicki, the filing said, told a special committee to the board of directors that she plans to speak with partners and other sources that could help finance the take-private, but would not support any “alternative transaction.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.